HUTCHMED (China) (HCM) Receivables - Other (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Receivables - Other of $20.2 million for Q2 2026, down 60.14% year-over-year from $50.7 million in Q2 2025, and down 60.14% quarter-over-quarter from $50.7 million in Q2 2025.
HUTCHMED (China) (HCM) Receivables - Other (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Receivables - Other for 12 consecutive years, with $20.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables - Other fell 60.14% year-over-year to $20.2 million; the TTM figure through Jun 2026 stood at $20.2 million (down 60.14% YoY), while the FY2025 annual figure was $51.8 million, up 555.73% from the prior year.
- Receivables - Other fell to $20.2 million in Q2 2026 per HCM's latest filing, from $50.7 million in the prior quarter.
- Across five years, Receivables - Other topped out at $73.0 million in Q2 2022 and bottomed at $14.7 million in Q2 2024.
- Historically, Receivables - Other has averaged $37.6 million across 5 years, with a median of $29.3 million in 2023.
- Annual changes were most pronounced in 2025 — Receivables - Other soared 244.31% — and 2026, when it plunged 60.14%.
- HUTCHMED (China)'s Receivables - Other stood at $73.0 million in 2022, then tumbled by 59.91% to $29.3 million in 2023, then plunged by 49.75% to $14.7 million in 2024, then jumped by 244.31% to $50.7 million in 2025, then plunged by 60.14% to $20.2 million in 2026.
- Business Quant data shows HCM's Receivables - Other at $20.2 million in Q2 2026, $50.7 million in Q2 2025, and $14.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.20 Mn |
| Jun 30, 2026 | 20.20 Mn |
| Jun 30, 2025 | 50.66 Mn |
| Jun 30, 2025 | 50.66 Mn |
| Jun 30, 2024 | 14.71 Mn |
| Jun 30, 2024 | 14.71 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Jun 30, 2022 | 73.03 Mn |
| Jun 30, 2022 | 73.03 Mn |
| Jun 30, 2021 | 32.12 Mn |
| Jun 30, 2021 | 32.12 Mn |
| Dec 31, 2020 | -9.60 Mn |
| Dec 31, 2020 | -9.60 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Dec 31, 2019 | -2.73 Mn |
| Dec 31, 2019 | -2.73 Mn |
| Sep 30, 2019 | 4.19 Mn |
| Sep 30, 2019 | 4.19 Mn |